Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir vs Efavirenz in HIV/TB Co-infected Patients
NCT02273765Phase 3Completed
- Sponsor
- ANRS
- Start
- Sep 2015
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of raltegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ANRS. Started Sep 2015; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02273765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02273765.